C4 Therapeutics (CCCC) Assets (2019 - 2026)
C4 Therapeutics' Assets was $359.4 million in Q2 2026, up 21.2% from $296.53 million a year earlier and up 9.3% from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Assets at C4 Therapeutics came in at $359.08 million, up 2.7% from FY2024.
- Assets shows a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- In earlier years, Assets was $349.6 million in FY2024 (-7.1%), $376.45 million in FY2023 (-12.6%), $430.84 million in FY2022 (-15.0%) and $506.77 million in FY2021 (+26.6%).
- The Q2 2026 figure marks the highest quarterly Assets since Q3 2024.
- Compared with a year earlier, Assets has increased for three straight quarters, with an average decline of 4.8% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2021 (growth of 121.7%); the worst was Q3 2025 (a decline of 29.4%).
- Per Business Quant data, CCCC's Assets in the three quarters before Q2 2026 was $328.86 million (Q1 2026), $359.08 million (Q4 2025) and $265.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | C4 Therapeutics | 383.47 Mn | -546.29 Mn | - | 359.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 359.40 Mn |
| Mar 31, 2026 | 328.86 Mn |
| Dec 31, 2025 | 359.08 Mn |
| Sep 30, 2025 | 265.49 Mn |
| Jun 30, 2025 | 296.53 Mn |
| Mar 31, 2025 | 319.52 Mn |
| Dec 31, 2024 | 349.60 Mn |
| Sep 30, 2024 | 376.06 Mn |
| Jun 30, 2024 | 381.09 Mn |
| Mar 31, 2024 | 398.37 Mn |
| Dec 31, 2023 | 376.45 Mn |
| Sep 30, 2023 | 333.01 Mn |
| Jun 30, 2023 | 375.01 Mn |
| Mar 31, 2023 | 396.04 Mn |
| Dec 31, 2022 | 430.84 Mn |
| Sep 30, 2022 | 461.44 Mn |
| Jun 30, 2022 | 492.48 Mn |
| Mar 31, 2022 | 515.49 Mn |
| Dec 31, 2021 | 506.77 Mn |
| Sep 30, 2021 | 507.91 Mn |
API Access
C4 Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();